Theodore Levin to Immunochemistry
This is a "connection" page, showing publications Theodore Levin has written about Immunochemistry.
Connection Strength
1.050
-
Optimizing colorectal cancer screening by getting FIT right. Gastroenterology. 2011 Nov; 141(5):1551-5.
Score: 0.395
-
Genetic Biomarker Prevalence Is Similar in Fecal Immunochemical Test Positive and Negative Colorectal Cancer Tissue. Dig Dis Sci. 2017 03; 62(3):678-688.
Score: 0.143
-
Beyond Colonoscopy: The Role of Alternative Screening Tests for Colorectal Cancer in Your Practice. Am J Gastroenterol. 2017 01; 112(1):8-10.
Score: 0.141
-
Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis. Ann Intern Med. 2014 Feb 04; 160(3):171.
Score: 0.117
-
Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics. J Natl Cancer Inst. 2007 Oct 03; 99(19):1462-70.
Score: 0.075
-
A Comparison of Fecal Immunochemical and High-Sensitivity Guaiac Tests for Colorectal Cancer Screening. Am J Gastroenterol. 2017 Nov; 112(11):1728-1735.
Score: 0.038
-
Colorectal cancer screening: Recommendations for physicians and patients from the U.S. Multi-Society Task Force on Colorectal Cancer. Gastrointest Endosc. 2017 07; 86(1):18-33.
Score: 0.037
-
Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2017 04; 152(5):1217-1237.e3.
Score: 0.035
-
Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol. 2017 01; 112(1):37-53.
Score: 0.035
-
Recommendations on fecal immunochemical testing to screen for colorectal neoplasia: a consensus statement by the US Multi-Society Task Force on colorectal cancer. Gastrointest Endosc. 2017 Jan; 85(1):2-21.e3.
Score: 0.035